About St James Uni Hospital; Icrf Cancer Medicine Research Unit
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Galina Velikova
1
Genentech, Inc.
1
University of Leeds
1
Clinical Trials at St James Uni Hospital; Icrf Cancer Medicine Research Unit
During the past decade, St James Uni Hospital; Icrf Cancer Medicine Research Unit conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma
In terms of collaborators to trials, out of the total clinical trials conducted in "St James Uni Hospital; Icrf Cancer Medicine Research Unit"
#1 collaborator was "The Leeds Teaching Hospitals NHS Trust" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at St James Uni Hospital; Icrf Cancer Medicine Research Unit
According to Clinical.Site data, the most researched conditions in "St James Uni Hospital; Icrf Cancer Medicine Research Unit" are
"Breast Cancer" (1 trials), "Cognitive Impairment" (1 trials), "Health-related Quality of Life" (1 trials), "Long-term Effects of Cancer Treatment" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "St James Uni Hospital; Icrf Cancer Medicine Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at St James Uni Hospital; Icrf Cancer Medicine Research Unit
Most popular intervention types in "St James Uni Hospital; Icrf Cancer Medicine Research Unit" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials), "Doxorubicin" (2 trials), "Pertuzumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at St James Uni Hospital; Icrf Cancer Medicine Research Unit
The vast majority of trials in "St James Uni Hospital; Icrf Cancer Medicine Research Unit" are
6 trials for "All" genders.
Clinical Trials Status at St James Uni Hospital; Icrf Cancer Medicine Research Unit
Currently, there are NaN active trials in "St James Uni Hospital; Icrf Cancer Medicine Research Unit".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in St James Uni Hospital; Icrf Cancer Medicine Research Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St James Uni Hospital; Icrf Cancer Medicine Research Unit, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".